First Turn Management »

Syndax Pharmaceuticals shares owned by First Turn Management

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $23M 1.2M 19.25

More positions owned by First Turn Management

Nuvalent Inc-a (NUVL)
Argenx Se Sponsored Adr (ARGX)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Vaxcyte (PCVX)
Axsome Therapeutics (AXSM)
Syndax Pharmaceuticals (SNDX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Natera (NTRA)
Intra Cellular Therapies (ITCI)
Crinetics Pharmaceuticals In (CRNX)
Transmedics Group (TMDX)
Arcellx Common Stock (ACLX)
Blueprint Medicines (BPMC)
Verona Pharma Sponsored Ads (VRNA)

View all positions for First Turn Management

Top funds holding Syndax Pharmaceuticals

BlackRock
BlackRock
Kynam Capital Management
Vanguard Group
State Street Corporation
Point72 Asset Management
Avidity Partners Management
Geode Capital Management
Stempoint Capital
OrbiMed Advisors
Woodline Partners
Franklin Resources
Goldman Sachs Group
First Turn Management
Aisling Capital Management

View all funds holding Syndax Pharmaceuticals